IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 1482 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
   Next article
   Previous article 
   Table of Contents
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   [PDF Not available] *
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article

 Article Access Statistics
    Viewed991    
    Printed13    
    Emailed0    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 


 
LETTER TO EDITOR
Year : 1997  |  Volume : 63  |  Issue : 3  |  Page : 212-213

Systemic corticosteroids in toxic epidermal necrolysis


Chandigarh, India

Correspondence Address:
Gurshan K Bedi
Chandigarh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 20944331

Rights and PermissionsRights and Permissions



How to cite this article:
Bedi GK, Thami GP, kanwar AJ. Systemic corticosteroids in toxic epidermal necrolysis. Indian J Dermatol Venereol Leprol 1997;63:212-3

How to cite this URL:
Bedi GK, Thami GP, kanwar AJ. Systemic corticosteroids in toxic epidermal necrolysis. Indian J Dermatol Venereol Leprol [serial online] 1997 [cited 2019 Dec 16];63:212-3. Available from: http://www.ijdvl.com/text.asp?1997/63/3/212/22757


To the Editor

We read with interest the letter by Sandipan Dhar (Ind J Dermatol Venereol Leprol 1996;62:270) regarding role of corticosteroids in toxic epidermal necrolysis (TEN). We are really at a loss to understand as to what the author exactly wants to convey. As in other disciplines of Medicine there are enough controversies in Dermatology. The role of corticosteroids in management of TEN is perhaps most interesting one. Whether corticosteroids are useful or not can only be shown by carrying out a well controlled study in which one group of patients receives corticosteroids early in the course of disease and in the other corticosteroids are not administered at all. There are a few well-controlled studies in the literature from very good centres around the world which clearly show that corticosteroids do not have any role in management of TEN; rather they predispose the patients to develop infections and increase the morbidity as well as mortality. Moreover prognosis in TEN is many a times determined by underlying conditions for which the offending drug was administered, and there are underlying diseases like tuberculosis in which corticosteroids may be contraindicated. We think that all of us who are in the field of Dermatology have enough knowledge and expertise about how to use corticosteroids. We welcome such comments from a fellow colleague if it is based upon well controlled scientific study. Finally, such publications do not add anything to existing knowledge about the subject; rather they further complicate the issues.




 

Top
Print this article  Email this article
Previous article Next article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow